Skip to main content
. 2024 Apr 27;16(2):58–65. doi: 10.17691/stm2024.16.2.06

Results of stereotactic photodynamic therapy of recurrent malignant gliomas

Author Number of patients Tumor volume (cm3), Me (min–max) Grade Median survivorship rate after stereotaxic photodynamic therapy (months)
Beck, et al. (2007) [12] 10 5.90 (2.10–10.20) III–IV 15
Johansson, et al. (2013) [39] 5 5.92 (1.50–10.0) IV 15
Lietke, et al. (2021) [32] 44 3.34 (0.50–22.80) III–IV 13
Data of the study 10 7.95 (3.20–22.50) III–IV Grade IV — 15.8, grade III — 46.3